A Dark Vector Cognition product

Item 6. Selected Financial Data

15K characters. Original on sec.gov · Markdown

Item 6. Selected Financial Data

The following information should be read in conjunction with Globe Life's Consolidated Financial Statements and related notes reported elsewhere in this Form 10-K:

(Dollar amounts in thousands except per share and percentage data)

Year ended December 31,
20192018201720162015
Life$2,517,784$2,406,555$2,306,547$2,189,333$2,073,065
Health1,077,3461,015,339976,373947,663925,520
Other4121538135
Total premium3,595,1343,421,9063,282,9353,137,0342,998,720
Net investment income910,459882,512847,885806,903773,951
Realized gains (losses)20,621(1,804)23,611(10,683)(8,791)
Total revenue4,527,5324,303,7514,155,5733,934,6293,766,065
Income from continuing operations, net of tax760,882701,5101,458,263539,590516,293
Income from discontinued operations, net of tax(92)(44)(3,769)10,18910,807
Net income760,790701,4661,454,494549,779527,100
Basic net income (loss) per common share:
Continuing operations6.976.2212.534.504.13
Discontinued operations——(0.03)0.080.08
Net income6.976.2212.504.584.21
Diluted net income (loss) per common share:
Continuing operations6.836.0912.264.414.07
Discontinued operations——(0.04)0.080.09
Net income6.836.0912.224.494.16
Cash dividends paid0.680.630.590.560.53
Basic weighted average shares outstanding109,214112,873116,343120,001125,095
Diluted weighted average shares outstanding111,381115,249118,983122,368126,757
As of December 31,
20192018201720162015
Cash and invested assets$19,923,204$17,239,570$17,853,047$15,955,891$14,405,073
Total assets25,977,46023,095,72223,474,98521,436,08719,853,213
Short-term debt298,738307,848328,067264,475490,129
Long-term debt1,348,9881,357,1851,132,2011,133,165743,733
Shareholders' equity7,294,3075,415,1776,231,4214,566,8614,055,552
Per diluted common share66.0248.1152.9537.7632.71
Effect of fixed maturity revaluation on diluted equity per common share(1)17.763.7913.185.632.62
Annualized premium in force:
Life2,581,6282,464,7282,373,0992,262,7362,150,498
Health1,139,0381,073,6981,018,020998,634973,042
Total3,720,6663,538,4263,391,1193,261,3703,123,540
Basic shares outstanding107,720110,693114,593118,031122,370
Diluted shares outstanding110,494112,561117,696120,958123,996

(1)See discussion under the caption Capital Resources in Management’s Discussion and Analysis in this report concerning the effect this rule has on Globe Life's equity.

GL 2019 FORM 10-K

CAUTIONARY STATEMENTS

We caution readers regarding certain forward-looking statements contained in the foregoing discussion and elsewhere in this document, and in any other statements made by, or on behalf of Globe Life whether or not in future filings with the Securities and Exchange Commission. Any statement that is not a historical fact, or that might otherwise be considered an opinion or projection concerning the Company or its business, whether express or implied, is meant as and should be considered a forward-looking statement. Such statements represent management's opinions concerning future operations, strategies, financial results or other developments. We specifically disclaim any obligation to update or revise any forward-looking statement because of new information, future developments, or otherwise.

Forward-looking statements are based upon estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond our control. If these estimates or assumptions prove to be incorrect, the actual results of Globe Life may differ materially from the forward-looking statements made on the basis of such estimates or assumptions. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:

1)Economic and other conditions leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and utilization of health care services that differ from Globe Life's assumptions;

2)Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement);

3)Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance;

4)Interest rate changes that affect product sales and/or investment portfolio yield;

5)General economic, industry sector or individual debt issuers’ financial conditions that may affect the current market value of securities we own, or that may impair an issuer’s ability to make principal and/or interest payments due on those securities;

6)Changes in pricing competition;

7)Litigation results;

8)Levels of administrative and operational efficiencies that differ from our assumptions;

9)The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;

10)The customer response to new products and marketing initiatives;

11)Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized; and

12)Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems.

Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission.

GL 2019 FORM 10-K

GLOBE LIFE INC.

Management's Discussion & Analysis

Previous: Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities · Next: Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations